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Introduction

Results

Penicillin allergy is reported by approximately 10%
of patients but it is estimated that less than 20%
of these patients have a true immune-mediated
allergy. Additionally, a documented penicillin allergy
has been associated with worse outcomes and
higher costs, likely because of the administration of
broad-spectrum antibiotics in an effort to avoid the
penicillin class. Staphylococcus aureus septicemia
is a serious infection with an estimated mortality
of 10-40%. Methicillin-sensitive S. aureus (MSSA)
septicemia is preferentially treated with ß-lactam
antibiotics as they improve mortality compared
with non-ß-lactams. ß-lactam antibiotics, such as
cefazolin, have a potential cross-reactivity of 10%
in penicillin-allergic patients. Thus, patients with a
reported penicillin allergy and MSSA septicemia may
be treated with inferior therapy to avoid potential
allergic reactions. An investigation into the outcomes
of patients, who presented to Lehigh Valley Hospital
with a reported penicillin allergy and S. aureus
bacteremia, was conducted to assess outcomes in
this population.

A total of 375 charts were reviewed. Fifty-six (15%) patients reported a penicillin allergy. Out
of thirty-two penicillin-allergic patients with MSSA, twenty-seven (84%) received ß-lactam
antibiotics. Penicillin-allergic patients stayed for a mean of 17.98 days (95% CI 13.00-22.97,
p<0.05) while non-allergic patients stayed for a mean of 17.02 days (95% CI 15.18-18.86,
p<0.05). Penicillin-allergic patients with MSSA stayed for a mean of 15.09 days (95% CI 10.5119.68, p<0.05). Penicillin-allergic patients with MSSA and treated with a ß-lactam stayed
for a mean of 14.85 days (95% CI 9.54 – 20.16, p<0.05) while penicillin-allergic patients
with MSSA and treated with a non-ß-lactam, stayed for a mean of 16.40 days (95% CI 5.4827.32, p=0.66). Ten (17.9%) patients with and forty-two (13.2%) without penicillin allergy
expired (p=0.349). Five (15.6%) penicillin-allergic patients with MSSA and five (20.8%) with
MRSA expired (p=0.730). Four (14.8%) penicillin-allergic patients with MSSA, who received a
ß-lactam, and one (20%), who received a non ß-lactam, expired (p=1.000).

Patient Outcome
Mortality

Problem Statement
The purpose of the study was to determine whether
the overall survival, length of stay, and antibiotic
regimens differed between patients with or without
penicillin allergy who presented to LVHN Cedar
Crest and Muhlenberg campuses with S. aureus
bacteremia.

Patient Outcome
Length of Stay

Methodology
A retrospective chart review of 375 patients, who
presented with S. aureus bacteremia from January
1st, 2013 to December 31st, 2013 and May
12th, 2014 to May 11th, 2015, was conducted to
compare outcomes of in-hospital mortality, length
of stay and antibiotic regimen among patients who
were or were not allergic to penicillin. Regulatory
approval was obtained from the LVHN Department
of Medicine, NORI, and IRB. Data was collected via
inpatient and outpatient records and entered into a
database. Demographic and clinical attributes of the
sample population were analyzed using descriptive
parameters, such as mean, while antibiotic regimen
and survival were analyzed using statistical tests
such as the Pearson Chi-Square test.

Conclusions and Future Implications
Penicillin-allergic patients had a higher rate of mortality, longer lengths of stay and received
non-ß-Lactam antibiotics more often. However, there was no statistically significant association
between penicillin allergy and survival, length of stay or antibiotic therapy used.
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